Dose-Effects Of Aorta-Infused Clenbuterol On Spinal Cord Ischemia-Reperfusion Injury In Rabbits

Binbin Chen,Yi Zhang,Lianhua Chen,Shiwei Huang,Shitong Li,Junyan Yao
DOI: https://doi.org/10.1371/journal.pone.0084095
IF: 3.7
2013-01-01
PLoS ONE
Abstract:Background: The beta(2) adrenergic receptor (beta(2)AR) plays an important role in ischemia-reperfusion (I/R) injury in various organs. Recently, a selective beta(2)AR agonist clenbuterol was suggested to protect against cerebral I/R injury. This study was designed to investigate changes of beta(2)ARs after spinal cord I/R injury and dose-effects of aorta-infused clenbuterol on spinal cord I/R injury in rabbits.Methods: Spinal cord ischemia was induced in New Zealand white rabbits by infrarenal abdominal aortic occlusion with a balloon catheter for 30 minutes except the sham group. During occlusion, nothing (I/R group), normal saline (NS group) or clenbuterol at different doses of 0.005, 0.01, 0.05, 0.1, 0.5, or 1 mg/kg (C-0.005, C-0.01, C-0.05, C-0.1, C-0.5, and C-1 groups) was infused into the occluded aortic segments. The hemodynamic data, blood glucose and serum electrolytes were measured during experimental period. Neurological function was assessed according to the modified Tarlov scales until 48 hours after reperfusion. After that, the lumbar spinal cord was harvested for beta(2)AR immunohistochemistry and histopathologic evaluation in the anterior horns.Results: The beta(2)AR expression in the anterior horns of the spinal cord was significantly higher in the I/R group than in the sham group. Tarlov scores and the number of viable a-motor neurons were higher in C-0.01-C-0.5 groups than in the NS group, C0.005 and C-1 groups and were highest in the C-0.1 group. Hypotension and hyperglycemia were found in the C-1 group.Conclusion: beta(2)ARs in the anterior horn were upregulated after spinal cord I/R injury. Aortic-infused clenbuterol (0.01-0.5 mg/kg) can attenuate spinal cord I/R injury dose-dependently during the ischemic period. The Optimal dosage was 0.1 mg/kg. Activation of beta(2)AR could be a new therapeutic strategy for the treatment of spinal cord I/R injury.
What problem does this paper attempt to address?